Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
EGFR expression + ALK positive
i
Other names:
EGFR, ERBB, ERBB1, Epidermal growth factor receptor, NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1956
;
238
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
EGFR exon 19 deletion (79)
EGFR amplification (52)
EGFR exon 18 deletion (3)
ALK amplification (3)
EGFR exon 2-7 deletion + EGFR amplification (2)
EGFR amplification + ERBB2 amplification (1)
EGFR exon 19 deletion + HER-2 amplification (1)
EGFR exon 21 deletion (1)
EGFR T790M + exon 19 deletion (0)
EGFR amplifcation (0)
EGFR exon 19 deletion (79)
EGFR amplification (52)
EGFR exon 18 deletion (3)
ALK amplification (3)
EGFR exon 2-7 deletion + EGFR amplification (2)
EGFR amplification + ERBB2 amplification (1)
EGFR exon 19 deletion + HER-2 amplification (1)
EGFR exon 21 deletion (1)
EGFR T790M + exon 19 deletion (0)
EGFR amplifcation (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
EGFR expression + ALK positive
Non Small Cell Lung Cancer
EGFR expression + ALK positive
Non Small Cell Lung Cancer
PD-L1 inhibitor
Resistant: A2 - Guideline
PD-L1 inhibitor
Resistant
:
A2
PD-L1 inhibitor
Resistant: A2 - Guideline
PD-L1 inhibitor
Resistant
:
A2
EGFR expression + ALK positive
Non Small Cell Lung Cancer
EGFR expression + ALK positive
Non Small Cell Lung Cancer
PD1 inhibitor
Resistant: A2 - Guideline
PD1 inhibitor
Resistant
:
A2
PD1 inhibitor
Resistant: A2 - Guideline
PD1 inhibitor
Resistant
:
A2
EGFR expression + ALK positive
Non Small Cell Lung Cancer
EGFR expression + ALK positive
Non Small Cell Lung Cancer
Tyrosine kinase inhibitor
Sensitive: C3 – Early Trials
Tyrosine kinase inhibitor
Sensitive
:
C3
Tyrosine kinase inhibitor
Sensitive: C3 – Early Trials
Tyrosine kinase inhibitor
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login